FDA Won’t Add “Black Box” Warning to COVID-19 Shots
News outlets have recently reported that the U.S. Food and Drug Administration (FDA) was considering adding a box warning (known for many years as a “Black Box” warning) to COVID-19 shots. A boxed warning appears prominently at the top of a drug’s prescribing information and represents the FDA’s strongest safety alert. The agency uses it […]
U.K. School Lockdowns Return Amid “Super Flu” Surge Reports
A “super-flu” strain is being reported across the United Kingdom, prompting several schools to close and increasing admissions to hospitals as influenza infection rates rise.1 The outbreak involves a mutation of the influenza A virus known as either H3N2 or as subclade K, emerging earlier in the winter than usual and contributing to disruption across […]
Concerns About Medical Errors Grow in More States
Recent reports from Oregon, Alabama, Louisiana, and Maryland indicate ongoing challenges in patient safety and communication when it comes to medical errors that harm patients. The findings show that many patients are not informed when medical errors occur, and some hospitals continue to struggle with safety practices that could prevent medical errors. Most Patients Harmed […]
Scientists Suggest Massaging Vaccines Into the Skin Could Eliminate Needle Injections
Scientists in France and the United Kingdom are investigating an alternative to traditional needle-based vaccines, one that uses mechanical stimulation of the skin to trigger an immune response. The research team, led by Élodie Segura, PhD, at the Institut Curie and Inserm in France, along with researchers at King’s College London, England, examined whether vaccines […]
Sanofi Reports Decline in Flu Vaccine Sales
Sanofi SA reported a decline in vaccine sales for the third quarter of 2025, citing reduced vaccination rates and increased pricing competition in Europe and the United States. The company’s legacy vaccine business dropped nearly eight percent to €3.36 billion (US$3.9 billion), while influenza and COVID-19 shot sales fell 17 percent to €1.53 billion (US$1.78 […]
Cancer Treatments Using mRNA Technology Targeted as COVID Shots Sales Decline
BioNTech SE and Moderna, Inc., two leading pharmaceutical companies that developed the mRNA COVID-19 biological, are facing new financial and regulatory challenges as demand for COVID booster shots continues to fall and U.S. health policy changes reshape the vaccine market.1 Moderna cut its 2025 sales forecast to between $1.5 billion and $2.2 billion, down as […]